Team Discovers How Tiny Parts of Cells Stay Organized, Adding New Insights for Blocking Cancer Growth
A significant advancement has been made in cancer research, as evidenced by a recent study published by a team of international researchers led by scientists at City of Hope. The research details a complex signaling process involving paxillin, a focal adhesion protein, which serves to connect with other proteins within cellular networks. Understanding this interaction may present new therapeutic targets for cancer treatment, particularly since the protein functions in a rather fluid state that could be exploited for precision medicine.
The Role of Paxillin in Cancer
Paxillin serves as a critical hub in cellular signaling pathways. According to Dr. Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology at City of Hope's comprehensive cancer center, "Disrupting the interaction of paxillin with other proteins bears direct relevance in cancer treatment." This disruption allows for the potential creation of precision therapeutics targeting paxillin’s specific functions that are predominantly active in cancer cells but less so in healthy cells.
Understanding Protein Interactions
For over three decades, Dr. Salgia and his team have studied paxillin and its function. The team identified that paxillin prompts cells to adapt to environmental changes, aiding tumor progression and treatment resistance. Their investigation has been focused on characterizing the binding interactions between paxillin and focal adhesion kinase (FAK), a crucial partner protein. This study adds vital information about the network of cellular proteins critical to cancer growth.
| Protein | Function | Relevance to Cancer |
|---|---|---|
| Paxillin | Focal adhesion protein | Promotes tumor adaptation and evasion of treatment |
| Focal Adhesion Kinase (FAK) | Regulates cell signaling | Involves in cell proliferation and survival in tumors |
Methodology and Results
Using a combination of advanced spectroscopy techniques and dynamic simulations, the research team delved into the structural characteristics of the paxillin-FAK interactions. They developed a computer-generated 3D model to demonstrate how these protein interactions transpire.
Dr. Supriyo Bhattacharya, Ph.D., assistant research professor in the Department of Computational and Quantitative Medicine at City of Hope, emphasized the significance of their methodological approach, stating,
“The combination of all these methods enabled us to accurately characterize the structural features of the paxillin-FAK interaction more than any single method on its own.”
| Research Method | Description | Implications |
|---|---|---|
| Spectroscopy | A technique related to medical MRI used to study protein structures. | Improves understanding of protein interactions. |
| Dynamic Simulations | Modeling the interactions and behaviors of proteins in various environments. | Enhances prediction of therapeutic targets. |
Potential for Cancer Therapy
The findings from this study open the door to develop precision therapeutics aimed at specific protein functions unique to cancer cells. This endeavor may be particularly important given that traditional therapies often affect both cancerous and healthy cells. By selectively targeting enzymes like paxillin that exhibit heightened activity in tumor growth, new treatment modalities could be developed.
Dr. Salgia stated, "Our results point to a novel mechanism of protein interaction that is less studied in the literature and indicates the possibility of such mechanisms being applicable to other disordered proteins."
Conclusion and Future Directions
The discovery of paxillin's detailed interactions with FAK underscores the potential of protein dynamics in advancing cancer therapies. This research is not only pivotal for understanding cancer growth but also for guiding future investigations into other disordered proteins. The interdisciplinary collaboration between researchers from various institutions like the University of Maryland and the National Institute of Standards and Technology emphasizes the collective effort needed to address complex cancer biology.
For further reading, the complete study can be found in Science Advances: here.
References
[1] Supriyo Bhattacharya et al., "Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domain," Science Advances (2025).
[2] Medical Xpress, retrieved June 22, 2025, from Medical Xpress.
Discussion